Preoperative Computed Tomography of Intrahepatic Mass-forming Cholangiocarcinomas: Morphologic Features and Enhancement Patterns Correlation with Clinicopathologic Factors and Clinical Outcomes

Authors

  • Wirana Angthong Department of Radiology, Thammasat University Hospital
  • Thararat Thana-arak Department of Radiology, Thammasat University Hospital
  • Wichet Piyawong Department of Radiology, Thammasat University Hospital

Keywords:

Cholangiocarcinoma, Computed tomography, Enhancement pattern

Abstract

Purpose: To evaluate preoperative morphologic features and enhancement patterns of intrahepatic mass-forming cholangiocarcinomas (IMCC) on CT and to determine the relationship between CT features, clinicopathologic factors, and clinical outcomes.
Materials and methods: Twenty patients with pathologically confirmed IMCC were included. Two radiologists independently evaluated the CT features and then reached consensus decisions. Histopathologic data and clinical outcomes after surgical resection were collected. Statistically significant CT parameters were identified through univariate analyse.

Results: Patients with negative preoperative CEA had longer disease free rate (DFR) than those with positive CEA (13.8 vs. 3.5 months; P = 0.014). Patients with tumors < 5 cm) had longer DFR than patients with tumors > 5 cm (16.5 vs 4.7 months; P = 0.006). Patients with
well moderately differentiated tumors demonstrated longer DFR than those with poorly differentiated tumors; P = 0.007. IMCC with daughter nodules had more frequent adjacent organ involvement at pathological examination (P = 0.005). IMCC with hepatic vein
invasion more frequently had margin involvement than those without hepatic vein invasion (P = 0.018).
Conclusion: Preoperative CEA levels, tumor sizes, daughter nodules, hepatic vein invasion, and pathological grades are significant prognostic factors of clinical outcome after surgical resection of IMCCs. Our results suggest that pre-operative CEA level and morphologic features of IMCC on CT may be useful to predict clinicopathological outcomes.

Downloads

Download data is not yet available.

References

Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol. 2013;11(1):13-21.

Razumilava N, Gores GJ. Cholangiocarcinoma. The Lancet. 2014;383(9935):2168-2179.

Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008;10(2):77-82.

Kirstein MM, Vogel A. Epidemiology and Risk Factors of Cholangiocarcinoma. Visc Med. 2016;32(6):395-400.

Saha SK, Zhu AX, Fuchs CS, Brooks GA. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise. Oncologist. 2016;21(5):594-599.

Han JK, Choi BI, Kim AY, et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics. 2002;22(1):173-187.

Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol. 2003;181(3):819-827.

Morimoto Y, Tanaka Y, Ito T, et al. Longterm survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2003;10(6):432–440.

Chung YE, Kim MJ, Park YN, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009;29(3):683-700.

Fabrega-Foster K, Ghasabeh MA, Pawlik TM, Kamel IR. Multimodality imaging of intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6(2):67-78.

Kim SJ, Lee JM, Han JK, Kim KH, Lee JY, Choi BI. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol. 2007;189(6):1428-1434.

Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188-1195.

Sun Ah Kim M, Jeong Min Lee M, Kyoung Bun Lee M, et al. Intrahepatic Mass-forming Cholangiocarcinomas: Enhancement Patterns at Multiphasic CT, with Special Emphasis on Arterial Enhancement Pattern—Correlation with Clinicopathologic Findings. Radiology. 2011;260(1):148-157.

Fujita N, Asayama Y, Nishie A, et al. Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings. Eur Radiol. 2017;27(2):498-506.

Ciresa M, Degaetano AM, Pompiri M, et al. Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features. European Review for Medical and Pharmacological Sciences. 2015;19:2786-2797.

Kim NR, Lee JM, Kim SH, et al. Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes. Clinical imaging. 2008,32(2):114-120.

Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR. 2001;176:1499–1507.

Nieun Seo Nieum, Do Young Kim, Jin-Young Choi. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis. AJR Am J Roentgenol. 2017;209:64-75.

Sakamoto Y, Kokudo N, Matsuyama Y, et al. Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan. Cancer. 2016;122:61–70.

Juntermanns B, Radunz S, Heuer M, et al. Tumor markers as a diagnostic key for hilar cholangiocarcinoma. Eur J Med Res. 2010;15(8):357-361.

Downloads

Published

2021-08-27

How to Cite

[1]
Angthong, W. , Thana-arak, T. and Piyawong, W. 2021. Preoperative Computed Tomography of Intrahepatic Mass-forming Cholangiocarcinomas: Morphologic Features and Enhancement Patterns Correlation with Clinicopathologic Factors and Clinical Outcomes. Asian Medical Journal and Alternative Medicine. 21, 2 (Aug. 2021), 124–133.

Issue

Section

Original Articles